4//SEC Filing
Mashiach Nissim 4
Accession 0001104659-23-095357
CIK 0001509745other
Filed
Aug 24, 8:00 PM ET
Accepted
Aug 25, 4:31 PM ET
Size
5.7 KB
Accession
0001104659-23-095357
Insider Transaction Report
Form 4
Mashiach Nissim
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-08-23+15,000→ 15,000 totalExercise: $2.21Exp: 2033-08-23→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]The Option was granted pursuant to Leap's 2022 Equity Incentive Plan, as amended. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of November 23, 2023, February 23, 2024, May 23, 2024 and August 23, 2024 for so long as the reporting person continues to be a director, consultant or service provider of the Company.
Documents
Issuer
LEAP THERAPEUTICS, INC.
CIK 0001509745
Entity typeother
Related Parties
1- filerCIK 0001357777
Filing Metadata
- Form type
- 4
- Filed
- Aug 24, 8:00 PM ET
- Accepted
- Aug 25, 4:31 PM ET
- Size
- 5.7 KB